Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bcc81b942fe7eaf94a3148ae29eed0f87> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bcc81b942fe7eaf94a3148ae29eed0f87 NCIT_P378 "NCI" @default.
- Bcc81b942fe7eaf94a3148ae29eed0f87 type Axiom @default.
- Bcc81b942fe7eaf94a3148ae29eed0f87 annotatedProperty IAO_0000115 @default.
- Bcc81b942fe7eaf94a3148ae29eed0f87 annotatedSource NCIT_C152237 @default.
- Bcc81b942fe7eaf94a3148ae29eed0f87 annotatedTarget "An orally bioavailable, small-molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. Upon administration, rivoceranib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF-stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this agent mildly inhibits c-Kit and c-SRC tyrosine kinases." @default.